written on 13.12.2016

Slovakia Pharma Report


This report offers companies, investors, policymakers, and stakeholders crucial insight into Slovakia; a country with both political and economic stability; a Eurozone member that stands out in its region for being a member of the single currency; and, for the second half of 2016, has held the rotating presidency of the Council of the European Union. Within this stable, integrated framework, Slovakia is making a name for itself in pharmaceuticals to complement its other major industries of automotives and IT.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Slovak healthcare and pharma sectors.

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here